Cervical Polyps — Cost, Top Hospitals & Success Rates | MyMedicPlus

Cervical polyps are benign, finger-like or rounded outgrowths arising from the surface epithelium or glands of the cervix. They are among the most common benign tumours of the female genital tract, found in approximately 2–5% of women of reproductive age and increasing in frequency in the perimenopausal and postmenopausal years.

Polyps are broadly classified by their anatomical origin:

• Endocervical polyps: The most common type, arising from the mucous membrane lining the endocervical canal. They are typically soft, reddish-pink, and pedunculated (on a stalk), and may prolapse through the external cervical os where they become visible on speculum examination. Endocervical polyps are composed of mucous glands and loose stromal tissue with abundant thin-walled blood vessels, which accounts for their tendency to bleed on contact.
• Ectocervical (exocervical) polyps: Less common, originating from the squamous epithelium covering the outer surface of the cervix (ectocervix). They are generally broader-based, firmer, and paler in colour than endocervical polyps.

The exact aetiology of cervical polyps is not fully established. Proposed mechanisms include chronic low-grade cervicitis, oestrogen stimulation (explaining their increased prevalence in the reproductive and perimenopausal years), focal inflammatory hyperplasia, and abnormal localised cell proliferation. Most polyps are asymptomatic and discovered incidentally during routine cervical screening. Symptomatic polyps typically cause intermenstrual bleeding, post-coital bleeding, or increased vaginal discharge.

Although cervical polyps are themselves benign lesions, they are clinically important because they cause symptoms that overlap significantly with more serious gynaecological pathology, necessitating investigation and removal.

Intermenstrual Bleeding (IMB)

Bleeding occurring between normal menstrual periods is one of the most common presenting symptoms of cervical polyps. The thin-walled blood vessels within endocervical polyps are fragile and can bleed spontaneously or with minimal trauma. Any woman with unexplained intermenstrual bleeding requires speculum examination to identify or exclude a cervical polyp.

Post-Coital Bleeding (PCB)

Bleeding after sexual intercourse is another hallmark symptom, occurring when the polyp is traumatised during penetration. Post-coital bleeding must always be investigated to exclude cervical carcinoma, cervicitis (including STIs), cervical ectropion, and endometrial pathology — all of which can coexist with or mimic a polyp.

Increased or Abnormal Vaginal Discharge

Endocervical polyps are lined by mucus-secreting columnar epithelium, which can produce increased, watery, or slightly blood-tinged discharge. Secondary infection of the polyp may cause purulent discharge.

Postmenopausal Bleeding (PMB)

Any vaginal bleeding occurring more than 12 months after the menopause must be investigated urgently to exclude endometrial carcinoma. Cervical polyps are one benign cause of PMB, but the risk of malignancy within the polyp itself is higher in the postmenopausal population (estimated 4–5%), and concurrent endometrial pathology must be excluded by transvaginal ultrasound and, where indicated, endometrial biopsy.

Infertility

Large endocervical polyps may occasionally obstruct the cervical canal or alter cervical mucus characteristics, though evidence that polyp removal improves fertility outcomes remains limited.

The decision to treat a cervical polyp depends on symptom burden, polyp characteristics, menopausal status, and the need for histopathological diagnosis.

Symptomatic Polyps

All symptomatic cervical polyps — those causing intermenstrual bleeding, post-coital bleeding, or abnormal discharge — should be removed to provide symptom relief and to enable histopathological examination, which remains the definitive method of excluding dysplasia and malignancy.

Postmenopausal Patients

Postmenopausal women with any cervical polyp, whether symptomatic or not, are generally offered removal due to the higher (though still absolute minority) malignancy risk and the importance of evaluating concurrent endometrial pathology.

Large or Multiple Polyps

Polyps greater than 3 cm in diameter, multiple polyps, or polyps with high vascularity seen on transvaginal ultrasound Doppler are preferentially managed by hysteroscopic removal in an operating theatre setting rather than office avulsion.

Asymptomatic Polyps in Premenopausal Women

The management of small, asymptomatic cervical polyps incidentally discovered at smear testing or speculum examination in premenopausal women is debated. Many guidelines support offering removal given the low procedural risk, the need for histological assessment, and the elimination of future bleeding episodes. Some clinicians adopt expectant management for very small (<1 cm), incidentally found polyps in young women, provided the cervical smear is up to date and normal. Patients should be informed of the small but non-negligible malignancy risk and offered removal if they prefer.

Failed or Incomplete Office Removal

If a polyp cannot be fully avulsed in the office setting (e.g., very broad-based stalk, high endocervical location, inability to visualise the full stalk), hysteroscopic removal is indicated to ensure completeness and to assess the endometrial cavity.

Cervical polyp removal is a straightforward and very low-risk procedure in most cases. The approach selected depends on polyp characteristics, patient factors, and available facilities.

1. Office Polypectomy (Avulsion / Torsion Polypectomy)

This is the standard outpatient technique for accessible, pedunculated endocervical polyps with a visible stalk emerging through the external os. The procedure requires no anaesthesia and is performed in the gynaecology clinic:

1. A speculum is inserted and the polyp is visualised.
2. The stalk is grasped firmly with ring forceps or sponge-holding forceps.
3. The polyp is avulsed by gentle torsion (twisting) or traction until the stalk separates.
4. The polyp base can be coagulated with silver nitrate or electrocautery to reduce bleeding and help ablate residual glandular tissue.
5. The specimen is placed in formalin and sent to histopathology.

The procedure causes minimal discomfort — similar to a cervical smear. Mild cramping for a few hours post-procedure is common. Success rates are high for suitable polyps, but recurrence rates of approximately 15% within 3 years reflect incomplete removal of the stalk base.

2. Hysteroscopic Polypectomy

Hysteroscopic removal is the gold standard for endocervical polyps whose stalk base cannot be visualised through the external os, for intracavitary (endometrial) polyps, for multiple polyps, for polyps in postmenopausal women, or when previous office avulsion was incomplete. The procedure is performed in the operating theatre (or, increasingly, in an outpatient hysteroscopy suite) under direct visualisation:

• A thin hysteroscope is introduced through the cervix under direct vision.
• The uterine cavity is distended with normal saline or glycine irrigation fluid to enable visualisation.
• The polyp is resected using scissors, monopolar electrosurgery, bipolar electrodes, or a morcellator (Myosure, TruClear) depending on polyp size and available equipment.
• The specimen is retrieved and sent for histopathology.

Outpatient hysteroscopic polypectomy under local anaesthesia (intra-cervical block) is feasible and well tolerated for polyps up to 2–3 cm in parous women. General anaesthesia (GA) or sedation is preferred for nulliparous women, anxious patients, or large/complex polyps.

3. LLETZ / Excision with Diathermy Loop

When a broad-based polyp is associated with surrounding cervical intraepithelial neoplasia (CIN) or when a full excision of the transformation zone is indicated on colposcopy, a large loop excision of the transformation zone (LLETZ, also called LEEP) may be performed simultaneously under colposcopic guidance. This is not routine for simple polyps but may be appropriate in the context of cervical screening abnormalities.

Removing a cervical polyp provides clinical, diagnostic, and psychological benefits:

• Symptom resolution: The vast majority of women report complete cessation or significant reduction of intermenstrual and post-coital bleeding after polypectomy. Studies report symptom resolution rates of 85–95% following complete hysteroscopic removal.
• Histopathological diagnosis: All removed polyps should be sent for formal histopathological examination by a pathologist. This is the only reliable way to exclude dysplasia (CIN or adenocarcinoma in situ of the cervix) or frank malignancy within the polyp. Published series report a malignancy rate of less than 1% in premenopausal women; rates up to 5% in postmenopausal women with symptomatic polyps have been reported, reinforcing the importance of routine histology.
• Peace of mind: Many women with unexpected bleeding experience significant anxiety about the possibility of cancer. Removal and histological confirmation of a benign polyp provides reassurance that enables psychological wellbeing.
• Prevention of recurrence and complications: Complete removal of the polyp stalk base by hysteroscopy reduces the recurrence rate to approximately 3–5% compared to 15% after office avulsion alone.
• Assessment of the endometrial cavity: Hysteroscopic polypectomy simultaneously evaluates the uterine cavity, allowing identification of concurrent endometrial polyps, submucosal fibroids, or endometrial abnormalities that might not be detected by ultrasound alone.

Cervical polypectomy is a low-risk procedure. The complication rate for office avulsion approaches zero for serious events, while hysteroscopic removal carries a very small but recognised operative risk.

Bleeding

Minor bleeding at the time of office avulsion is universal and usually minimal. Significant haemorrhage requiring packing or cautery is rare (<1%). Post-procedural light spotting or discharge for 7–10 days is normal. Heavy post-procedural bleeding, or bleeding accompanied by fever, should prompt clinical review.

Infection

Post-procedural infection (endometritis or pelvic inflammatory disease) is uncommon, estimated at 0.5–1% for hysteroscopic procedures. Many units administer prophylactic antibiotics before hysteroscopy in higher-risk patients (history of PID, immunosuppression). Symptoms of infection include lower abdominal pain, fever, and offensive discharge appearing 2–5 days post-procedure.

Incomplete Removal and Recurrence

Office avulsion can leave residual glandular epithelium at the stalk base, accounting for the 15% recurrence rate. Complete hysteroscopic resection under direct vision significantly reduces this risk.

Uterine Perforation (Hysteroscopy Only)

Uterine perforation during hysteroscopy occurs in approximately 0.5–1% of cases, more commonly when the uterus is retroverted or when the cervix requires significant dilation. Most perforations are clinically benign and managed conservatively; laparoscopy or laparotomy is required only if bowel injury or significant haemorrhage is suspected.

False Reassurance if Histology Not Performed

Not sending a removed polyp for histopathology — while uncommon in well-resourced settings — is the most clinically significant error in polyp management. The rare but important malignancies within polyps would be missed, delaying treatment. Histology is mandatory for all removed cervical polyps.

Post-polypectomy follow-up is structured according to histopathological findings, menopausal status, and the completeness of the initial procedure.

Immediately After Procedure

• Light spotting or watery discharge for 7–14 days is expected and normal.
• Avoid sexual intercourse, tampons, and swimming for 7 days post-procedure.
• Paracetamol or ibuprofen for mild cramping — NSAIDs also reduce prostaglandin-mediated cramping from uterine distension fluid.

Histopathology Review

Results are typically available within 1–2 weeks. The majority of polyps will show benign endocervical or endometrial epithelium with or without inflammation — no further treatment is required. If the histology shows:

• Benign polyp with complete excision: Clinical review or discharge depending on symptom status.
• Endocervical adenocarcinoma in situ (AIS): Urgent referral to a gynaecological oncologist — large cone biopsy or hysterectomy will typically be recommended.
• Invasive carcinoma: Urgent oncological referral and staging investigations.
• CIN within the polyp: Management according to cervical screening guidelines — usually colposcopy and LLETZ.

Speculum Examination and Cervical Screening

A speculum examination 3–6 months after polypectomy allows visual confirmation that the polyp has not recurred. Ongoing participation in the national cervical screening programme (HPV testing and cytology at appropriate intervals) is important, as a history of cervical polyps does not itself alter the standard screening schedule.

Postmenopausal Women: Endometrial Assessment

For postmenopausal women, concurrent transvaginal ultrasound to measure the endometrial thickness should be performed. An endometrial thickness ≥4 mm in a postmenopausal woman requires endometrial biopsy (Pipelle sampling) to exclude endometrial hyperplasia or carcinoma, regardless of whether a polyp was the cause of the presenting PMB.

The cost of cervical polyp removal varies primarily according to whether the procedure is performed in an outpatient office setting or in an operating theatre, and whether hysteroscopy is required.

Key Cost Drivers

• Procedure setting: Office polypectomy without anaesthesia is the least expensive approach and may be covered by routine gynaecological consultation fees. Hysteroscopic polypectomy requires a theatre or endoscopy suite, equipment, and (for GA cases) anaesthesia.
• Anaesthesia: Local anaesthetic block adds minimal cost to outpatient hysteroscopy; GA adds USD 500–1,500 depending on country and duration.
• Histopathology: Mandatory sending of the specimen for histological examination adds a laboratory processing fee, typically USD 50–300 depending on the number of specimens.
• Concurrent investigations: Transvaginal ultrasound, colposcopy, or endometrial biopsy performed at the same episode increase total costs.
• Country: Wide variation exists globally. Medical tourism is increasingly common for elective gynaecological procedures, with India, Thailand, and Eastern Europe offering substantial savings.

Approximate Cost Ranges by Country

• United States: Office polypectomy USD 300–700; hysteroscopic polypectomy (GA) USD 2,500–6,000
• United Kingdom (private): Office GBP 300–600; hysteroscopic GBP 1,500–3,500
• India: Hysteroscopic polypectomy USD 400–900
• Thailand: USD 600–1,500
• Turkey: USD 500–1,200

While removal is the standard recommendation for cervical polyps, there are scenarios where a conservative (expectant) approach is acceptable, and it is important for women to understand their options.

Expectant Management for Asymptomatic Polyps

For small (<1 cm), asymptomatic, pedunculated endocervical polyps in premenopausal women with an up-to-date normal cervical smear, expectant management (observation at the next routine smear) is practised by some clinicians. A 2020 retrospective cohort study found a malignancy rate of 0% in asymptomatic polyps removed from women under 45 years. However, most guidelines still favour removal because polyps may become symptomatic, and histology cannot be obtained without removal.

Spontaneous Polyp Loss

A small proportion of soft, pedunculated polyps detach spontaneously, particularly after menstruation. This is not a reliable or recommended treatment strategy, as the stalk base typically remains and regeneration occurs.

Hormonal Treatment

There is no evidence that hormonal therapy (progestogens, combined oral contraceptives) reliably causes cervical polyps to regress. Hormonal therapy may be used to manage the underlying symptom (intermenstrual bleeding) while awaiting a scheduled polypectomy appointment, but it is not a treatment for the polyp itself.

Alternative Removal Techniques for Specific Scenarios

• Carbon dioxide or diode laser vaporisation: Can be used under colposcopic guidance for small ectocervical polyps, though histological diagnosis of the base is lost.
• Cryotherapy: Rarely used for cervical polyps given the inability to obtain histology from the treated tissue.

For all women, the discussion of management options should consider symptom burden, the importance of histological diagnosis, menopausal status, and individual patient preference — in keeping with shared decision-making principles.